← brief for 2026-10-07 · Slowing decline

Effect of Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors on Chronic Kidney Disease Progression: A Systematic Review.

Paper A Peer reviewed Meta-analysis or large trial

Key takeaways

This review looked at many studies on SGLT2 inhibitors. These are drugs that help control blood sugar and protect the kidneys. The review found that these drugs slow the loss of kidney function. This is strong evidence that the drugs help people with kidney disease, whether or not they have diabetes.

Who did this work

Nenova DD · Yankov YG · Chausheva GM

Source

Paper · PubMed, the drug frontier · 2026 Sep 5
https://pubmed.ncbi.nlm.nih.gov/42840550/